| P/E (FY) | — | Sales (TTM) | $221,765 |
| Earnings (TTM) | -$125,638 | ROE | — |
| Net Margin | −222.19% | ROIC | — |
| Debt / Equity | 0.45 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $27.3M | Trading Days | 388 |
| 52W High | 4.79 |
| 52W Low | 0.26 |
| % Off High | −81.21% |
| YTD | 225.60% | 1Y | 76.47% |
| Since incept. (ann.) | 113.75% |
| Ann. Volatility (1Y) | 650.20% | Ann. Volatility (3Y) | 521.43% |
| Sharpe (1Y) | 1.15 | Sharpe (3Y) | 1.02 |
| Max Drawdown (1Y) | −88.57% | Max Drawdown (3Y) | −88.57% |
| Beta (3Y, vs SPY) | −1.38 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ARAY | ACCURAY INC | $29.0M | — |
| BEAT | HeartBeam, Inc. | $29.3M | — |
| TELA | TELA Bio, Inc. | $30.0M | — |
| PETV | PetVivo Holdings, Inc. | $24.1M | — |
| NSPR | InspireMD, Inc. | $32.1M | — |
| CTSO | Cytosorbents Corp | $23.2M | — |
| RVP | RETRACTABLE TECHNOLOGIES INC | $20.1M | — |
| MCAG | Mountain Crest Acquisition Corp. V | $38.1M | — |
| PAVM | PAVmed Inc. | $39.1M | — |
| AURX | Nuo Therapeutics, Inc. | $43.6M | — |
| OSRH | OSR Health, Inc. | $16.0M | — |
| SRTS | Sensus Healthcare, Inc. | $48.4M | — |
